Eyecare biotech jumps 19% after stablecoin-focused pivot
NovaBay Pharmaceuticals was founded in 2000 as a biopharmaceutical company developing eye care products and is now betting big on the Sky protocol and stablecoins.
NovaBay Pharmaceuticals was founded in 2000 as a biopharmaceutical company developing eye care products and is now betting big on the Sky protocol and stablecoins.
Original source
Read on CointelegraphRelated market context
Ripple chases AI’s machine economy as XRPL stablecoins near $1 billion
Stablecoin liquidity on the XRP Ledger (XRPL) has nearly doubled over the past month, putting the network within reach of a $1 bil...
Citi Launches Crypto Platform to Tokenize Private Company Shares
Just in, Citi(Citigroup) is launching a crypto platform to tokenize and trade shares of late-stage private companies for instituti...
‘I Never Said the Company Could Not Sell Bitcoin’: Saylor Walks Back ‘Never Sell’ at BTC Prague
Strategy founder Michael Saylor told the BTC Prague conference he “never said the company could not sell bitcoin,” clarifying the...
BTC Jumps 3% on Iran Peace Deal But Fed Meeting Keeps Institutions Cautious
Bitcoin News: BTC price climbed from $61,100 to above $63,400 on June 11 after President Trump cancelled planned Iran strikes and...
IEM Cologne Major drops crypto sponsors entirely as esports pivots to traditional funding
Esports' shift from crypto to traditional funding may stabilize financial backing, fostering long-term growth and sustainability i...
Citigroup to bring private company shares onto blockchain as SpaceX and Anthropic IPOs loom
Citigroup's move could democratize access to high-growth private investments, potentially reshaping private market dynamics and li...